Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Doxycycline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for doxycycline and what is the scope of doxycycline patent protection?

is the generic ingredient in seventeen branded drugs marketed by Galderma Labs Lp, Heritage Pharms Inc, Pfizer, Zydus Pharms Usa Inc, Rachelle, Mylan, Sandoz Inc, Lupin Ltd, Watson Labs, Aqua Pharms, G And W Labs Inc, Sun Pharm Inds Ltd, Chartwell Life Sci, Par Pharm, Impax Labs Inc, Sun Pharm Inds, Mylan Pharms Inc, Lannett, Hikma Intl Pharms, Mylan Labs Ltd, Mutual Pharm, Halsey, Actavis Labs Fl Inc, Pvt Form, Aqua Pharms Llc, Actavis Elizabeth, Vintage Pharms, Collagenex, West-ward Pharms Int, Tolmar, Warner Chilcott, Heather, Interpharm, Ivax Sub Teva Pharms, Superpharm, Caribe Holdings, Fresenius Kabi Usa, Ranbaxy, Medicis, Teva, Mayne Pharma Intl, Corepharma, Pliva, Larken Labs, Amneal Pharms, Prinston Inc, and Mayne Pharma, and is included in eighty-nine NDAs. There are eighteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Doxycycline has forty patent family members in twelve countries.

There are twenty-seven drug master file entries for doxycycline. Thirty-nine suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: doxycycline

Drug Master File Entries: see list27
Suppliers / Packagers: see list39
Bulk Api Vendors: see list31
Clinical Trials: see list76
Patent Applications: see list2,079
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxycycline at DailyMed

Pharmacology for Ingredient: doxycycline

Drug ClassTetracycline-class Drug

Tentative approvals for DOXYCYCLINE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe40MGCAPSULE;ORAL
► Subscribe► Subscribe40MGCAPSULE; ORAL
► Subscribe► Subscribe40MGCAPSULE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
TABLET;ORAL065070-001Dec 15, 2000ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL091052-001Feb 8, 2012ABRXNoNo► Subscribe► Subscribe
doxycycline hyclate
CAPSULE;ORAL062469-001Oct 31, 1984DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
doxycycline hyclate
INJECTABLE;INJECTION062569-001Mar 9, 1988APRXNoYes► Subscribe► Subscribe
doxycycline hyclate
TABLET;ORAL065182-001May 13, 2005DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus